Trijardy XR 12.5 mg/1

Trijardy XR 12.5 mg/1 combines empagliflozin, linagliptin, and metformin hydrochloride for blood sugar management. This extended-release tablet is designed for oral use and is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. in the USA.

Trijardy XR 12.5 mg/1 is commonly used for managing type 2 diabetes. It works by combining three active ingredients to help control blood sugar levels. This medication is often prescribed as part of a broader diabetes management plan, which may include diet and exercise. People often ask, 'What is Trijardy XR used for?' and the answer is primarily for blood sugar control in adults with type 2 diabetes.

Common effects of Trijardy XR 12.5 mg/1 may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some users may also experience hypoglycemia, especially when combined with other diabetes medications. It's important to monitor blood sugar levels regularly while using this medication.

Trijardy XR 12.5 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions. This medication should be stored at room temperature and kept out of reach of children. Always consult a healthcare provider before starting or stopping any medication.

Trijardy XR 12.5 mg/1 may interact with other medications, including certain antibiotics, antifungals, and HIV protease inhibitors. It is also important to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.